Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials

Stein-Gold, Linda; Kircik, Leon; Draelos, Zoe Diana; Werschler, Philip; DuBois, Janet; Lain, Edward; Baumann, Leslie; Goldberg, David; Kaufman, Joely; Tanghetti, Emil; Ahluwalia, Gurpreet; Alvandi, Nancy; Weng, Emily; Berk, David

Stein-Gold, Linda; Kircik, Leon; Draelos, Zoe Diana; Werschler, Philip; DuBois, Janet; Lain, Edward; Baumann, Leslie; Goldberg, David; Kaufman, Joely; Tanghetti, Emil; Ahluwalia, Gurpreet; Alvandi, Nancy; Weng, Emily; Berk, David.

J Drugs Dermatol ; 17(11): 1201-1208, 2018 11 01.

Article in En | MEDLINE | ID: mdl-30500142

Subject(s)

Erythema/drug therapy; Oxymetazoline/therapeutic use; Rosacea/complications; Skin Cream/therapeutic use; Sympathomimetics/therapeutic use; Adult; Erythema/diagnosis; Erythema/etiology; Female; Humans; Male; Self-Assessment; Severity of Illness Index; Treatment Outcome; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxymetazoline / Sympathomimetics / Rosacea / Erythema / Skin Cream Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2018 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links